[{"Assets_0_Q3_USD":124493000.0,"CommonStockSharesOutstanding_0_Q3_shares":22313001.0,"NetIncomeLoss_1_Q3_USD":-15088000.0,"NetIncomeLoss_3_Q3_USD":-41699000.0,"StockholdersEquity_0_Q3_USD":96714000.0,"Ticker":"SNDX","CIK":"1395937","name":"SYNDAX PHARMACEUTICALS INC","OfficialName":"Syndax Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"934158860.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171108"}]